EUVIMEDEUVIMED entdecken
Crossref

Normolipidemic Dysglycemia in Type 2 Diabetes: Clinical and Biochemical Characteristics of a Cohort Free of Lipid-Lowering and Chronic Anti-Inflammatory Therapy

Ali Zeynettin iD, Orhan Balikci, İsmail Demir

Hormone and Metabolic Research · 01.08.2026 · 58 (08) · 299-310

DOI: 10.1055/a-2901-3276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.08.2026. Verfasst von Ali Zeynettin und 2 weiteren Autor:innen. Beteiligte Einrichtung: İzmir Bozyaka Education and Research Hospital, Department of Internal Medicine, Türkiye, İzmir. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Anti-Inflammatory Agents, Dyslipidemias, Hyperglycemia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AbstractIn type 2 diabetes, hyperglycaemia usually clusters with atherogenic dyslipidaemia and low-grade inflammation; yet, these axes may dissociate in some patients. We aimed to estimate the prevalence of a normolipidemic dysglycemia phenotype in adults with type 2 diabetes and characterise its clinical–biochemical profile within an analytical window free of lipid-lowering and chronic anti-inflammatory/immunomodulatory therapy. In this retrospective, cross-sectional study, we analysed records of 1,046 adults aged 25–60 years with type 2 diabetes from a tertiary care hospital between 2020 and 2024. Individuals with other diabetes types, acute inflammatory conditions, malignancy, advanced organ failure and non-euthyroid status were excluded. Normolipidemic dysglycemia was defined as glycated hemoglobin≥64 mmol/mol with low-density lipoprotein cholesterol

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Anti-Inflammatory AgentsDyslipidemiasHyperglycemiaLipidsHumansFemaleMaleMiddle AgedAdultRetrospective StudiesCross-Sectional StudiesBlood Glucose

Substanzen

Anti-Inflammatory AgentsBlood GlucoseLipids

Autor:innen und Institutionen

  • İzmir Bozyaka Education and Research Hospital, Department of Internal Medicine, Türkiye, İzmir.
  • Ministry of Health İzmir City Hospital, Department of Internal Medicine, Türkiye, İzmir.

ORCID-Profile: Ali Zeynettin

Zitieren

APA

Zeynettin, A., Balikci, O., & Demir, İ. (2026). Normolipidemic Dysglycemia in Type 2 Diabetes: Clinical and Biochemical Characteristics of a Cohort Free of Lipid-Lowering and Chronic Anti-Inflammatory Therapy. Hormone and Metabolic Research, 58(08), 299-310. https://doi.org/10.1055/a-2901-3276

Vancouver

Zeynettin A, Balikci O, Demir İ. Normolipidemic Dysglycemia in Type 2 Diabetes: Clinical and Biochemical Characteristics of a Cohort Free of Lipid-Lowering and Chronic Anti-Inflammatory Therapy. Hormone and Metabolic Research. 2026;58(08):299-310. doi:10.1055/a-2901-3276

BibTeX
@article{Zeynettin2026,
  author = {Zeynettin, Ali and Balikci, Orhan and Demir, İsmail},
  title = {Normolipidemic Dysglycemia in Type 2 Diabetes: Clinical and Biochemical Characteristics of a Cohort Free of Lipid-Lowering and Chronic Anti-Inflammatory Therapy},
  journal = {Hormone and Metabolic Research},
  year = {2026},
  volume = {58},
  number = {08},
  pages = {299--310},
  doi = {10.1055/a-2901-3276}
}
Kostenlos starten →